Kopran Limited reported a 33% YoY decline in consolidated net profit to ₹2,573.12 lakhs for FY26, with revenue up 8.2% to ₹68,142.36 lakhs.
Board recommended a dividend of ₹3.00 per equity share (30% on face value of ₹10) for FY26, subject to shareholder approval.
Appointed Mrs. Namrata Somani as Additional Director (Non-Executive, Promoter Group) effective May 19, 2026.
Received NCLT approval for amalgamation scheme with Kopran Laboratories Ltd, with appointed date of January 1, 2025.